Quantcast

Latest Aripiprazole Stories

2008-10-03 12:00:27

Orexigen Therapeutics, a biopharmaceutical company focused on the treatment of obesity and other central nervous system-related disorders, has initiated its first Phase IIa clinical trial with OREX-003, a proprietary sustained release formulation of zonisamide plus olanzapine. The Phase IIa clinical trial, OZ-101, is designed to examine the effectiveness of OREX-003 in mitigating drug-associated weight gain or other metabolic consequences commonly experienced by patients taking atypical...

2006-05-26 10:30:00

NEW YORK -- The anti-psychotic drug Abilify (aripiprazole) appears to be a safe and effective treatment for patients with borderline personality disorder, often leading to improvements in health-related quality of life and interpersonal problems, a study suggests. Personality disorder is a type of mental illness in which people have trouble functioning with others. It can be associated with depression and psychopathological symptoms. A few neuroleptic agents have been used in therapy for...

2005-11-25 15:22:51

By Karla Gale NEW YORK (Reuters Health) - The atypical antipsychotic drug Abilify (aripiprazole) appears to enhance the response to antidepressants in patients with treatment-resistant major depression, research suggests. Atypical antipsychotic agents are often used to augment antidepressants among patients with refractory mood disorders, lead author Dr. George I. Papakostas and colleagues note in their report, published in the Journal of Clinical Psychiatry. Abilify is unique among...

2005-10-18 20:48:41

Some newer antipsychotic medications may be associated with a small increased risk of death when used to treat elderly dementia patients, psychiatrists at Johns Hopkins warn. In an editorial published in the Oct. 19 issue of the Journal of the American Medical Association, Peter V. Rabins, M.D., M.P.H., and Constantine G. Lyketsos, M.D., M.H.S., professors of psychiatry at The Johns Hopkins University School of Medicine, cautioned that clinicians should consider both the risks and benefits...

2005-10-18 20:29:26

Atypical antipsychotic drugs seem to confer a small increased risk for death when used in people with dementia, concludes a team of researchers from the Keck School of Medicine of the University of Southern California in a meta-analysis of 15 clinical trials published in the October 19 issue of the Journal of the American Medical Association. Despite this risk, says Lon Schneider, M.D., professor of psychiatry, neurology, and gerontology at the Keck School and the USC Andrus School of...

2005-10-18 16:52:47

CHICAGO (Reuters) - Newer anti-psychotic drugs appear to cause a small increased risk of death among patients with dementia, according to a report published on Tuesday. Researchers at the University of California in Los Angeles said the finding, based on a review of 15 studies, indicates that such drugs should be discontinued if dementia patients do not show improvement in the initial stages of treatment. Currently the medications are sometimes prescribed for long periods of time to...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related